{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:46:52Z","timestamp":1790801212495,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phrs.2026.108142","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:55:10Z","timestamp":1771260910000},"page":"108142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Urinary \u03949-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-5220","authenticated-orcid":false,"given":"Danielle","family":"McCartney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-4271","authenticated-orcid":false,"given":"Christopher","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108142_bib1","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2025: Key figures at a glance. 2025, Vienna: United Nations."},{"key":"10.1016\/j.phrs.2026.108142_bib2","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2025: Statistical Annex. 2025, Vienna: United Nations."},{"key":"10.1016\/j.phrs.2026.108142_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neubiorev.2021.01.003","article-title":"Determining the magnitude and duration of acute \u0394(9)-tetrahydrocannabinol (\u0394(9)-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review","volume":"126","author":"McCartney","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2026.108142_bib4","unstructured":"International Council on Alcohol, D.T.S.I., Cannabis & Driving: Introduction. ICADTS. Available from: \u3008https:\/\/www.icadtsinternational.com\/resources\/Documents\/Fact%20Sheets\/ICADTS-Cannabis-Introduction-16.pdf\u3009."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib5","first-page":"1","article-title":"11-nor-9-carboxy-\u22069-tetrahydrocannabinol \u2013 A ubiquitous yet underresearched cannabinoid. A review of the literature","volume":"9","author":"Ujv\u00e1ry","year":"2014","journal-title":"Cannabinoids"},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1021\/acschemneuro.8b00651","article-title":"Dark classics in chemical neuroscience: \u0394(9)-tetrahydrocannabinol","volume":"10","author":"Banister","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2026.108142_bib7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13181-016-0587-z","article-title":"Interpretation of workplace tests for cannabinoids","volume":"13","author":"Kulig","year":"2017","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.phrs.2026.108142_bib9","unstructured":"Standards Australia & Standards New Zealand, Procedures for specimen collection and the detection and quantification of drugs in urine (AS\/NZS 4308:2023). 2023."},{"key":"10.1016\/j.phrs.2026.108142_bib10","unstructured":"U.S. Department of Transportation, 49C.F.R. \u00a7 40.85 \u2014 Cutoff concentrations for urine drug tests. 2025."},{"key":"10.1016\/j.phrs.2026.108142_bib11","unstructured":"European Workplace Drug Testing Society, European Guidelines for Workplace Drug Testing in Urine. 2023."},{"key":"10.1016\/j.phrs.2026.108142_bib12","unstructured":"World Anti-doping Agency (WADA), 2023 List of Prohibited Substances and Methods \u2013 Explanatory Note. 2022, Montr\u00e9al: WADA."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib13","article-title":"The marijuana detection window: Determining the length of time cannabinoids will remain detectable in urine following smoking","volume":"5","author":"Cary","year":"2003","journal-title":"Drug Court Rev."},{"issue":"8","key":"10.1016\/j.phrs.2026.108142_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.200790152","article-title":"Human Cannabinoid Pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.phrs.2026.108142_bib15","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., (editors), Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). 2024: Cochrane."},{"key":"10.1016\/j.phrs.2026.108142_bib16","unstructured":"Food and Drug Administration (FDA), Bioanalytical Method Validation: Guidance for Industry, U.S.D.o.H.a.H. Services, Editor. 2018. Available from: \u3008www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry\u3009."},{"key":"10.1016\/j.phrs.2026.108142_bib17","doi-asserted-by":"crossref","unstructured":"Wickham, H., ggplot2: Elegant Graphics for Data Analysis. 2016, New York: Springer-Verlag.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"10.1016\/j.phrs.2026.108142_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.774846","article-title":"Use ggbreak to effectively utilize plotting space to deal with large datasets and outliers","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2026.108142_bib19","author":"Wilke","year":"2024","journal-title":"cowplot Streamline Plot Theme Plot Annot. 'ggplot2"},{"key":"10.1016\/j.phrs.2026.108142_bib20","author":"Yu","year":"2023","journal-title":"aplot Decor. a 'ggplot' Assoc. Inf."},{"key":"10.1016\/j.phrs.2026.108142_bib21","article-title":"_shiny: Web Application Framework for R","volume":"1","author":"Chang","year":"2025","journal-title":"R. Package Version"},{"key":"10.1016\/j.phrs.2026.108142_bib22","unstructured":"Sievert, C., Cheng, J. & Aden-Buie, G., _bslib: Custom 'Bootstrap' 'Sass' Themes for 'shiny' and 'rmarkdown'_. R package version 0.9.0. 2025."},{"key":"10.1016\/j.phrs.2026.108142_bib23","doi-asserted-by":"crossref","unstructured":"Sievert, C., Interactive Web-Based Data Visualization with R, plotly, and shiny. 2020, Florida: CRC.","DOI":"10.1201\/9780429447273"},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib24","first-page":"2","article-title":"_stringr: Simple, Consistent Wrappers for Common String Operations","volume":"1","author":"Wickham","year":"2025","journal-title":"R. Package Version"},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib25","first-page":"2","article-title":"_patchwork: The Composer of Plots","volume":"1","author":"Pedersen","year":"2025","journal-title":"R. Package Version"},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib26","first-page":"7","article-title":"_wesanderson: A Wes Anderson Palette Generator","volume":"0","author":"Ram","year":"2023","journal-title":"R. Package Version"},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/dta.3327","article-title":"Risk of unintentional antidoping rule violations by consumption of hemp products","volume":"15","author":"Mareck","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jat\/bkab059","article-title":"Urinary pharmacokinetic profile of cannabidiol (CBD), \u22069-tetrahydrocannabinol (THC) and their metabolites following oral and vaporized CBD and vaporized CBD-dominant cannabis administration","volume":"46","author":"Sholler","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jat\/bkaa191","article-title":"Characterization of cannabidiol in alternative biological specimens and urine, after consumption of an oral capsule","volume":"46","author":"Ameline","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib30","doi-asserted-by":"crossref","first-page":"11792","DOI":"10.1038\/s41598-024-62428-x","article-title":"An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis","volume":"14","author":"Bawa","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jat\/bkae001","article-title":"Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products","volume":"48","author":"Zamarripa","year":"2024","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00414-022-02896-w","article-title":"Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment","volume":"137","author":"Franz","year":"2023","journal-title":"Int. J. Leg. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib33","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ptr.6931","article-title":"Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis","volume":"35","author":"P\u00e9rez-Acevedo","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2026.108142_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110561","article-title":"Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking","volume":"318","author":"Gerace","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.phrs.2026.108142_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2017.12.033","article-title":"Detection of delta-9-tetrahydrocannabinol (THC) in oral fluid, blood and urine following oral consumption of low-content THC hemp oil","volume":"284","author":"Hayley","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/dta.2062","article-title":"Determination of cannabinoids in hemp nut products in Taiwan by HPLC-MS\/MS coupled with chemometric analysis: Quality evaluation and a pilot human study","volume":"9","author":"Chang","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00043764-199906000-00018","article-title":"Concentration of marijuana metabolites in the urine after ingestion of hemp seed tea","volume":"41","author":"Steinagle","year":"1999","journal-title":"J. Occup. Environ. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/15563659709001246","article-title":"Efficacy of two commercial products for altering urine drug test results","volume":"35","author":"Coleman","year":"1997","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11419-024-00686-0","article-title":"Determination of \u03949-tetrahydrocannabinol, 11-nor-carboxy-\u03949-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake","volume":"42","author":"Papoutsis","year":"2024","journal-title":"Forensic Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamapsychiatry.2020.3567","article-title":"Urinary tetrahydrocannabinol after 4 weeks of a full-spectrum, high-cannabidiol treatment in an open-label clinical trial","volume":"78","author":"Dahlgren","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jat\/28.3.160","article-title":"Urinary pharmacokinetics of 11-nor-9-carboxy-\u03949-tetrahydrocannabinol after controlled oral \u03949-tetrahydrocannabinol administration","volume":"28","author":"Gustafson","year":"2004","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108142_bib42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jat\/25.8.691","article-title":"Evaluating the impact of hemp food consumption on workplace drug tests","volume":"25","author":"Leson","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jat\/24.7.562","article-title":"Consumption and quantitation of \u03949-tetrahydrocannabinol in commercially available hemp seed oil products","volume":"24","author":"Bosy","year":"2000","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108142_bib44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jat\/bkac042","article-title":"Urinary excretion profile of cannabinoid analytes following acute administration of oral and vaporized cannabis in infrequent cannabis users","volume":"46","author":"Sholler","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1515\/cclm-2019-0119","article-title":"THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of \"light cannabis\"","volume":"58","author":"Pacifici","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00414-018-01994-y","article-title":"Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a \u201ctobacco substitute\u201d","volume":"133","author":"H\u00e4dener","year":"2019","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.phrs.2026.108142_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.forsciint.2018.08.009","article-title":"Cannabinoid concentrations in blood and urine after smoking cannabidiol joints","volume":"291","author":"Meier","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1515\/cclm-2018-0566","article-title":"Determination of cannabinoids in oral fluid and urine of \"light cannabis\" consumers: A pilot study","volume":"57","author":"Pacifici","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jat\/bkab035","article-title":"Safety, pharmacokinetics and pharmacodynamics of Spectrum Red Softgels in healthy participants","volume":"46","author":"Peters","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14010059","article-title":"Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis","volume":"14","author":"Busard\u00f2","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bkz038","article-title":"Urinary excretion profile of 11-nor-9-carboxy-\u03949-tetrahydrocannabinol (THCCOOH) following smoked and vaporized cannabis administration in infrequent cannabis users","volume":"44","author":"Spindle","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jat\/bkx102","article-title":"Pharmacokinetic characterization of 11-nor-9-carboxy-\u03949-tetrahydrocannabinol in urine following acute oral cannabis ingestion in healthy adults","volume":"42","author":"Schlienz","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/bkab026","article-title":"Safety, pharmacokinetics and pharmacodynamics of Spectrum Yellow Oil in healthy participants","volume":"46","author":"Peters","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib54","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1089\/can.2022.0179","article-title":"\u03949-THC and CBD in olasma, oral fluid, exhaled breath, and urine from 23 patients administered Sativex","volume":"9","author":"Mel\u00e9n","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.18433\/J3F31D","article-title":"Comparison of cannabinoid concentrations in plasma, oral fluid and urine in occasional cannabis smokers after smoking cannabis cigarette","volume":"19","author":"Marsot","year":"2016","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jat\/28.7.546","article-title":"Passive cannabis smoke exposure and oral fluid testing","volume":"28","author":"Niedbala","year":"2005","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jat\/25.7.565","article-title":"\u03949-Tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol\u00ae: Results of a clinical study","volume":"25","author":"Elsohly","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jat\/21.5.373","article-title":"Excretion of cannabinoids in urine after ingestion of cannabis seed oil","volume":"21","author":"Lehmann","year":"1997","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jat\/20.6.441","article-title":"Urinary excretion profiles of 11-nor-9-carboxy-\u03949-tetrahydrocannabinol in humans after single smoked doses of marijuana","volume":"20","author":"Huestis","year":"1996","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jat\/14.3.176","article-title":"Human urinary excretion profile after smoking and oral administration of [14c]\u03941-tetrahydrocannabinol","volume":"14","author":"Johansson","year":"1990","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jat\/10.2.56","article-title":"GC\/MS and EMIT analyses for \u03949-tetrahydrocannabinol metabolites in plasma and urine of human subjects","volume":"10","author":"McBurney","year":"1986","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.phrs.2026.108142_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cca.2020.08.014","article-title":"Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use","volume":"510","author":"Koch","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2026.108142_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.forsciint.2016.03.031","article-title":"The therapeutic use of cannabinoids: Forensic aspects","volume":"265","author":"Indorato","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jat\/29.7.607","article-title":"Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle","volume":"29","author":"Niedbala","year":"2005","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jat\/25.5.289","article-title":"Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana","volume":"25","author":"Niedbala","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jat\/12.4.169","article-title":"Marijuana-laced brownies: Behavioral effects, physiologic effects, and urinalysis in humans following ingestion","volume":"12","author":"Cone","year":"1988","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jat\/bkaa046","article-title":"Free and glucuronide urine cannabinoids after controlled smoked, vaporized and oral cannabis administration in frequent and occasional cannabis users","volume":"44","author":"Huestis","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"23","key":"10.1016\/j.phrs.2026.108142_bib68","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1007\/s00216-016-9765-8","article-title":"Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips","volume":"408","author":"Andersson","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.phrs.2026.108142_bib69","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2013.214106","article-title":"Urinary cannabinoid disposition in occasional and frequent smokers: Is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?","author":"Desrosiers","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phrs.2026.108142_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-009-3431-3","article-title":"Plasma and urine profiles of \u03949-tetrahydrocannabinol and its metabolites 11-hydroxy-\u03949-tetrahydrocannabinol and 11-nor-9-carboxy-\u03949-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes","author":"Brenneisen","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib71","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jat\/13.4.218","article-title":"Urinary excretion half-life of \u03941-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking","volume":"13","author":"Johansson","year":"1989","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11419-016-0330-0","article-title":"Urinary cannabinoid levels during nabiximols (Sativex\u00ae)-medicated inpatient cannabis withdrawal","volume":"35","author":"Kevin","year":"2017","journal-title":"Forensic Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib73","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/dta.2959","article-title":"Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use","volume":"13","author":"Mareck","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/dta.2230","article-title":"Optimization of recombinant \u03b2-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry","volume":"10","author":"Sempio","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.phrs.2026.108142_bib75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.forsciint.2017.01.008","article-title":"Topical application of THC containing products is not able to cause positive cannabinoid finding in blood or urine","volume":"272","author":"Hess","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"23-24","key":"10.1016\/j.phrs.2026.108142_bib76","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.cca.2012.06.034","article-title":"Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry","volume":"413","author":"Scheidweiler","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib77","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/jat\/25.7.538","article-title":"Temporal indication of marijuana use can be estimated from plasma and urine concentrations of \u03949-tetrahydrocannabinol, 11-hydroxy-\u03949-tetrahydrocannabinol, and 11-nor-\u03949-tetrahydrocannabinol-9-carboxylic acid","volume":"25","author":"Manno","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib78","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jat\/21.6.482","article-title":"Hemp oil ingestion causes positive urine tests for \u03b49- tetrahydrocannabinol carboxylic acid","volume":"21","author":"Costantino","year":"1997","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib79","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jat\/17.5.292","article-title":"Validity testing of the EZ-SCREEN cannabinoid test","volume":"17","author":"Jenkins","year":"1993","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.phrs.2026.108142_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.150269","article-title":"Partitioning of phytocannabinoids between faeces and water \u2013 Implications for wastewater-based epidemiology","volume":"805","author":"Pandopulos","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib81","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jat\/16.4.228","article-title":"Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users","volume":"16","author":"Kelly","year":"1992","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jat\/23.5.323","article-title":"Urinary excretion of 11-nor-9-carboxy-\u03949-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users","volume":"23","author":"Smith-Kielland","year":"1999","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib83","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-024-06826-4","article-title":"A feasibility study to assess the recruitment and retention of pregnant patients who regularly use cannabis","volume":"17","author":"Vanderziel","year":"2024","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.phrs.2026.108142_bib84","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2016.08.622","article-title":"A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users","volume":"167","author":"Schuster","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.phrs.2026.108142_bib85","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881114550354","article-title":"Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - A multi-voxel pattern analysis","volume":"28","author":"Cheng","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108142_bib86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2012.07.016","article-title":"Striatal D2\/D3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users","volume":"128","author":"Albrecht","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib87","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5490","article-title":"Variation in cannabinoid metabolites present in the urine of adults using medical cannabis products in Massachusetts","volume":"4","author":"Gilman","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.phrs.2026.108142_bib88","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jat\/32.8.562","article-title":"Urinary elimination of 11-nor-9-carboxy-\u03949-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence","volume":"32","author":"Goodwin","year":"2008","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0269881119872206","article-title":"Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence","volume":"34","author":"Schuster","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib90","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10461-017-1782-x","article-title":"Cannabis use, medication management and adherence among persons living with HIV","volume":"21","author":"Vidot","year":"2017","journal-title":"AIDS Behav."},{"issue":"4","key":"10.1016\/j.phrs.2026.108142_bib91","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MPG.0000000000003220","article-title":"Urinary cannabis metabolite concentrations in cannabis hyperemesis syndrome","volume":"73","author":"Cordova","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"9","key":"10.1016\/j.phrs.2026.108142_bib92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: Imaging with the novel radiotracer [11C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.phrs.2026.108142_bib93","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: Effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108142_bib94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary \u03949-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib95","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/00952990.2023.2232525","article-title":"Self-report methodology for quantifying standardized cannabis consumption in milligrams delta-9-tetrahydrocannabinol","volume":"49","author":"Larsen","year":"2023","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib96","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s10815-020-01762-1","article-title":"Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis","volume":"37","author":"Lee","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib97","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/FTD.0000000000000092","article-title":"Detection time for THC in oral fluid after frequent cannabis smoking","volume":"36","author":"Andas","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib98","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.07.021","article-title":"\u03949-Tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol","volume":"106","author":"Levin","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2-3","key":"10.1016\/j.phrs.2026.108142_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2009.07.027","article-title":"Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence","volume":"106","author":"Peters","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.phrs.2026.108142_bib100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1360-0443.2008.02292.x","article-title":"Marijuana withdrawal and craving: Influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes","volume":"103","author":"Haughey","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jat\/28.1.35","article-title":"An investigation of the stability of free and glucuronidated 11-nor-\u03949-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples","volume":"28","author":"Skopp","year":"2004","journal-title":"J. Anal. Toxicol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108142_bib102","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/jcm11133717","article-title":"Correlation of nabiximols dose to steady-state concentrations of cannabinoids in urine samples from patients with multiple sclerosis","volume":"11","author":"Birke","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00414-015-1241-z","article-title":"Rapid elimination of carboxy-THC in a cohort of chronic cannabis users","volume":"130","author":"Lewis","year":"2016","journal-title":"Int. J. Leg. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108142_bib104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bcpt.12235","article-title":"Can physical exercise or food deprivation cause release of fat-stored cannabinoids?","volume":"115","author":"Westin","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1360-0443.2010.03228.x","article-title":"Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users","volume":"106","author":"Schwilke","year":"2011","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.phrs.2026.108142_bib106","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/jat\/33.9.610","article-title":"Urinary excretion of 11-nor-9-carboxy-\u03949- tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use","volume":"33","author":"Westin","year":"2009","journal-title":"J. Anal. Toxicol."},{"issue":"3-4","key":"10.1016\/j.phrs.2026.108142_bib107","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-004-1885-8","article-title":"Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study","volume":"176","author":"Kanayama","year":"2004","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2026.108142_bib108","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002130050951","article-title":"Changes in aggressive behavior during withdrawal from long-term marijuana use","volume":"143","author":"Kouri","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2026.108142_bib109","doi-asserted-by":"crossref","DOI":"10.2196\/58499","article-title":"Avatar Intervention in virtual reality for cannabis use disorder in individuals with severe mental disorders: Results from a 1-year, single-arm clinical trial","volume":"11","author":"Giguere","year":"2024","journal-title":"JMIR Ment. Health"},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2215-0366(18)30427-9","article-title":"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: A double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial","volume":"6","author":"D'Souza","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.phrs.2026.108142_bib111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2017.05.006","article-title":"A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls","volume":"194","author":"Rabin","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2026.108142_bib112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.forsciint.2015.01.026","article-title":"Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use","volume":"249","author":"Odell","year":"2015","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib113","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1037\/pha0000747","article-title":"Urinalysis and perceived effects following 2-week use of a commercial broad-spectrum cannabidiol product","volume":"33","author":"Zvorsky","year":"2024","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12883-024-03646-8","article-title":"An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies","volume":"24","author":"Brett","year":"2024","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/FTD.0000000000001032","article-title":"Likelihood of positive urine screens of THC-COOH after daily use of full-spectrum hemp extracts varies as a function of screening criterion used","volume":"45","author":"Ferretti","year":"2023","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib116","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11419-022-00652-8","article-title":"Cannabidiol in urine is not a proof of CBD consumption\u2014lesson learned from urine sample analysis in routine caseworks","volume":"41","author":"Deville","year":"2023","journal-title":"Forensic Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108142_bib117","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15563650.2020.1827148","article-title":"Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products","volume":"59","author":"Goggin","year":"2021","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108142_bib118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4323\/rjlm.2010.133","article-title":"High-throughput toxicological analysis of \u03949-THC and 11-nor-9-carboxy-\u03949-THC by LC\/MS\/MS","volume":"18","author":"Vlase","year":"2010","journal-title":"Rom. J. Leg. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108142_bib119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12995-025-00468-3","article-title":"Pre-employment urine drug screening: Examining trends in THC-COOH positivity rates post-legalization of recreational cannabis in California - a retrospective review","volume":"20","author":"Sharip","year":"2025","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.phrs.2026.108142_bib120","unstructured":"World Anti-doping Agency (WADA), World Anti-Doping Code International Standard Prohibited List 2026. 2025, Montr\u00e9al: WADA."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:29:26Z","timestamp":1777606166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":120,"alternative-id":["S1043661826000575"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108142","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary \u03949-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108142"}}